|
CMTM6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.00789999679662E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.13389997391522E-09 |
| Normal-vs-Stage2 |
1.628370E-01 |
| Normal-vs-Stage3 |
1.628170E-04 |
| Normal-vs-Stage4 |
1.106240E-02 |
| Stage1-vs-Stage2 |
2.157800E-02 |
| Stage1-vs-Stage3 |
1.922640E-01 |
| Stage1-vs-Stage4 |
1.388200E-01 |
| Stage2-vs-Stage3 |
2.002400E-01 |
| Stage2-vs-Stage4 |
4.645000E-01 |
| Stage3-vs-Stage4 |
6.333600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.204999984469E-09 |
| Normal-vs-AfricanAmerican |
1.040470E-02 |
| Normal-vs-Asian |
1.716030E-03 |
| Caucasian-vs-AfricanAmerican |
9.098200E-01 |
| Caucasian-vs-Asian |
9.309400E-01 |
| AfricanAmerican-vs-Asian |
8.809600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.68970000000002E-05 |
| Normal-vs-Female |
1.31489999999346E-08 |
| Male-vs-Female |
5.392800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.07990002998315E-09 |
| Normal-vs-Age(41-60Yrs) |
2.16399999999339E-05 |
| Normal-vs-Age(61-80Yrs) |
2.213900E-02 |
| Normal-vs-Age(81-100Yrs) |
9.404300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.747600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.419600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.736600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.092800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.768600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.608200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.003600E-01 |
| Classical-VS-Follicular |
7.99529999984117E-08 |
| Classical-VS-Other |
2.839800E-01 |
| Classical-VS-Normal |
1.82910353530019E-11 |
| Tall-VS-Follicular |
2.540500E-03 |
| Tall-VS-Other |
3.407200E-01 |
| Tall-VS-Normal |
5.961200E-04 |
| Follicular-VS-Other |
4.791400E-01 |
| Follicular-VS-Normal |
6.087800E-01 |
| Other-VS-Normal |
3.616400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.989000E-04 |
| Normal-vs-N1 |
2.001100E-03 |
| N0-vs-N1 |
3.197800E-01 |
|
|
